Pharmapedia

Speeded-Up Drug Approval Process Will Boost Biologics Market

  • Posted on: 4 July 2018
  • By: PharmaTutor News

The US Federal Drug Administration is aiming to cut the time-to-market and the development costs for new drugs. This will help drive growth in the market for biologics, where over 1000 drugs are currently under development, to 9.6% year on year from its recent rate of 5.4%. Unlike small-molecule drugs that are manufactured through organic or inorganic chemical synthesis, biologics are manufactured by living cells. Biologics are more complex, fragile and difficult to manufacture than small molecules. They cost more to bring to market than the $2 billion average to develop a new drug, despite a trend to outsource development to contract research organizations.

ADVANCED TECHNOLOGY ON ACCURACY IN DETECTION OF BREAST CANCER

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
SUJATHA RAMASAMY 1*, SRIKANTA PRIYADARSHAN PATRA 1,PULAK RANJAN BASAK 1,
1Technology Information, Forecasting and Assessment Council (TIFAC)-DST, New Delhi, India.
*sujathar23@gmail.com

ABSTRACT:
Breast cancer is one of the leading type of cancer in India. Current methods used in detection of cancer like mammography combined with Digital Infrared Imaging can help learn about  earlier stages of cancer with accuracy.The Niramai an Indian startup developed a software with machine learning and artificial intelligence which can detect and sense cancer cells that are 5 times smaller than what has been done presently. The method is non-contact, painless and free of radiation. This method can help detection of cancer in very early stage before showing any suspicious or alarming signs.

Growth In The Pharmaceuticals Market

The global pharma market was worth $934.8 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, a report from The Business Research Company shows. This is an accelerated pace compared to 5.2% for the years before 2017, but is slower than the other two large healthcare segments, medical equipment and healthcare services. Healthcare as a whole is growing at over 7% year on year.

Indian Patent act need revisions, requests Indian and Foreign pharmaceutical associations

  • Posted on: 11 April 2018
  • By: PharmaTutor News

Indian and foreign pharmaceutical associations need amendment in section 146 of Indian patent act 1970 and form 27 for making Indian patenting system more efficient and it will eliminate vague and unnecessary annual working statement disclosures. Indian patent office has invited responses from stake holders and many pharmaceutical industries and association responded in this regards.

Next stop for Indian pharma companies should be Japan

  • Posted on: 11 April 2018
  • By: PharmaTutor News

Japan continues to be one of the largest pharmaceutical markets in the globe only behind US and China. The country of 12-13 crores population and have greatest potential in pharmaceutical despite difficult demographic landscape. Life expectancy of Japanese population is higher in the world which is almost 80 years for male and 87 years for female. Older people need more medicine and this is the fundamental of pharmaceutical industry in the Japan.

FIRST FDA APPROVED DIGITAL MEDICINE – BRIEF NOTE

ABOUT AUTHOR
Rajesh S Vagh
PharmaTutor Edu Labs,
Surat, Gujarat, India
rajesh@pharmatutor.org

Last year in November, FDA had approved first DIGITAL MEDICINE, ABILIFY MYCITE which is a drug-device combination product comprised of Otsuka's oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor. In simple word, it is an aripiprazole tablet with sensor. It is indicated in adults for the treatment of schizophrenia, bipolar I disorder,  acute treatment of manic and mixed episodes as monotherapy and as adjunct to lithium or valproate, maintenance treatment as monotherapy and as adjunct to lithium or valproate and  adjunctive treatment of major depressive disorder.

KNOW ALL ABOUT THE E-PHARMACIES IN INDIA

Today we live in a digital era where everything is available at your doorstep on just a finger click. Whether it is grocery items, food stuffs or medicine, you can order it online getting it delivered in a meanwhile of time. Initiative of Indian Government i.e. Digital India has opened a new ray of hope to E-commerce industry in India making people specially from Tier 2 and 3 cities become more inclined to learn and use of these applications of online shopping.

RETHINKING PACKAGING WITH R&D

ABOUT AUTHOR
Soumyanath Mishra
Head & DGM, Packaging Development-F&D
Mankind Research Centre
soumyanath.mishra@mankindpharma.com

Packaging is an important component in the development of various drug formulations in pharmaceutical industry. Packaging of pharmaceutical dosage forms has a close relationship between a pharmaceutical preparation and its package which is a major concern to the drug stability and safety. The selection of Packaging material is made on the basis of its efficacy and performance characteristics in preserving the quality, potency and safety of the pharmaceutical products. The stability testing of pharmaceutical products and compatibility testing of packaging materials is an integral part of R&D in pharmaceutical industry. The stability of a drug in solid and liquid dosage forms depends on the efficacy of the packaging materials to protect the drug from chemical degradation and changes in physical characteristics such as appearance, hardness, friability, dissolution, disintegration, weight variation, moisture contents and mechanical durability.

Pages